16 November 2020 Step up for TB 2020 - Social Media Gallery, Animated Images Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Statement | 17 November 2014 Research and development R&D cost estimates - MSF response to Tufts CSDD study on cost to develop a new drug Photograph by Sami Siva Press release Press release | 17 November 2014 Tropical & neglected diseases India India: MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State Opinion article | 13 November 2014 Tuberculosis Mind the Deadly Gaps Photograph by Martin Zinggl Press release Press release | 13 November 2014 Intellectual property and trade First trials for Ebola treatments to start at MSF sites in December 5 min Events | 04 November 2014 African Society for Laboratory Medicine Conference 2014 Statement | 03 November 2014 Hepatitis C Intellectual property and trade MSF responds to BMS commercial strategy for hepatitis C drug daclatasvir in developing countries 5 min Photograph by Wendy Marijnissen Press release Press release | 30 October 2014 Tuberculosis MSF sounds alarm on practices and policies dangerously out of step with what’s needed to contain the global drug-resistant TB crisis Photograph by Julien Rey/MSF Press release Press release | 24 October 2014 Tropical & neglected diseases Ebola: MSF urges immediate action on vaccines and treatments for frontline workers Load More
Statement | 17 November 2014 Research and development R&D cost estimates - MSF response to Tufts CSDD study on cost to develop a new drug
Photograph by Sami Siva Press release Press release | 17 November 2014 Tropical & neglected diseases India India: MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State
Photograph by Martin Zinggl Press release Press release | 13 November 2014 Intellectual property and trade First trials for Ebola treatments to start at MSF sites in December 5 min
Statement | 03 November 2014 Hepatitis C Intellectual property and trade MSF responds to BMS commercial strategy for hepatitis C drug daclatasvir in developing countries 5 min
Photograph by Wendy Marijnissen Press release Press release | 30 October 2014 Tuberculosis MSF sounds alarm on practices and policies dangerously out of step with what’s needed to contain the global drug-resistant TB crisis
Photograph by Julien Rey/MSF Press release Press release | 24 October 2014 Tropical & neglected diseases Ebola: MSF urges immediate action on vaccines and treatments for frontline workers